LYTIR

Insider · SEC Form 4 · Chief Financial Officer

Matthias Bodenstedt

Filed with the SEC as Bodenstedt Matthias; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.2M of MLTX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. MLTXSold: MoonLake Immunotherapeutics Jun 22, 2026 39,120 shares filed Jun 23, 2026 1,115,435 shares held directly after, as filed 10b5-1 plan filing $862K
  2. MLTXSold: MoonLake Immunotherapeutics Jun 18, 2026 2,794 shares filed Jun 18, 2026 1,154,555 shares held directly after, as filed 10b5-1 plan filing $55K
  3. MLTXSold: MoonLake Immunotherapeutics Jun 17, 2026 15,082 shares filed Jun 18, 2026 1,157,349 shares held directly after, as filed 10b5-1 plan filing $297K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.